COVID-19 Severity Prediction Test
COVID-19
DevelopmentActive
Key Facts
About Age Labs
Age Labs is a Norwegian life science company that develops diagnostic tests for early detection of age-related diseases using advanced machine learning on epigenetic datasets. Their pipeline includes a groundbreaking early detection test for rheumatoid arthritis, a biological age predictor, and COVID-19 severity prediction tests, alongside custom biomarker development services for pharmaceutical and nutraceutical industries.
View full company profileTherapeutic Areas
Other COVID-19 Drugs
| Drug | Company | Phase |
|---|---|---|
| Remdesivir (Veklury) | Gilead Sciences | Approved |
| mRNA-1273 (Spikevax) | Moderna | Approved |
| Investigational Oral COVID-19 Antiviral | Shionogi | Clinical |
| ZyCoV-D | Zydus Lifesciences | Approved |
| BBIBP-CorV | Sinopharm | Approved |
| SARS-CoV-2 Neutralizing Antibodies | Adaptive Biotechnologies | Discovery |
| Covovax™ | Novavax | Approved/Commercial |
| LY-CoV555 (Bamlanivimab) | AbCellera | Emergency Use Authorization (Past) |
| ARCT-154 (Bivalent) | Arcturus Therapeutics | Phase 1/2 |
| LUNAR-COV19 (ARCT-021) | Arcturus Therapeutics | Phase 1/2 |
| Paxlovid (Nirmatrelvir) Manufacturing Enzyme | Codexis | Commercial |